 | • レポートコード：MRC2-11QY04029 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肥満治療のグローバル市場について調査・分析したレポートです。種類別（手術・インプラント装置、薬物療法、食事療法、その他）市場規模、用途別（子供、大人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肥満治療の競争状況、市場シェア ・世界の肥満治療市場：種類別市場規模 2015年-2020年（手術・インプラント装置、薬物療法、食事療法、その他） ・世界の肥満治療市場：種類別市場規模予測 2021年-2026年（手術・インプラント装置、薬物療法、食事療法、その他） ・世界の肥満治療市場：用途別市場規模 2015年-2020年（子供、大人） ・世界の肥満治療市場：用途別市場規模予測 2021年-2026年（子供、大人） ・北米の肥満治療市場分析：米国、カナダ ・ヨーロッパの肥満治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肥満治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肥満治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肥満治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：NutriSystem, Inc. (U.S.)、Kellogg Company (U.S.)、Ethicon, Inc. (U.S.)、Medtronic (U.S.)、F. Hoffmann-La Roche (Switzerland)、Atkins Nutritionals, Inc. (U.S.)、Herbalife Ltd. (U.S.)、Covidien plc (U.S.)、Apollo Endosurgery (U.S.)、Amer Sports (Finland)、Johnson Health Technology, Ltd. (Taiwan)、Cybex International (U.S.)、USGI Medical (U.S.)、Olympus Corporation (Japan)、Brunswick Corporation (U.S.)、Technogym SpA (Italy) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Obesity Treatment Market
The global Obesity Treatment market size is projected to reach US$ 5620.7 million by 2026, from US$ 4912 million in 2020, at a CAGR of 13.4%% during 2021-2026.
Global Obesity Treatment Scope and Market Size
Obesity Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Obesity Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
Market segment by Type, the product can be split into
Surgical & Implant Devices
Medication Therapy
Dietary
Other
Market segment by Application, split into
Children
Adults
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Obesity Treatment Revenue
1.4 Market by Type
1.4.1 Global Obesity Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgical & Implant Devices
1.4.3 Medication Therapy
1.4.4 Dietary
1.4.5 Other
1.5 Market by Application
1.5.1 Global Obesity Treatment Market Share by Application: 2020 VS 2026
1.5.2 Children
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Obesity Treatment Market Perspective (2015-2026)
2.2 Global Obesity Treatment Growth Trends by Regions
2.2.1 Obesity Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Obesity Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Obesity Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Obesity Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Obesity Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Obesity Treatment Players by Market Size
3.1.1 Global Top Obesity Treatment Players by Revenue (2015-2020)
3.1.2 Global Obesity Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Obesity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Obesity Treatment Market Concentration Ratio
3.2.1 Global Obesity Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Obesity Treatment Revenue in 2019
3.3 Obesity Treatment Key Players Head office and Area Served
3.4 Key Players Obesity Treatment Product Solution and Service
3.5 Date of Enter into Obesity Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Obesity Treatment Historic Market Size by Type (2015-2020)
4.2 Global Obesity Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Obesity Treatment Market Size by Application (2015-2020)
5.2 Global Obesity Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Obesity Treatment Market Size (2015-2020)
6.2 Obesity Treatment Key Players in North America (2019-2020)
6.3 North America Obesity Treatment Market Size by Type (2015-2020)
6.4 North America Obesity Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Obesity Treatment Market Size (2015-2020)
7.2 Obesity Treatment Key Players in Europe (2019-2020)
7.3 Europe Obesity Treatment Market Size by Type (2015-2020)
7.4 Europe Obesity Treatment Market Size by Application (2015-2020)
8 China
8.1 China Obesity Treatment Market Size (2015-2020)
8.2 Obesity Treatment Key Players in China (2019-2020)
8.3 China Obesity Treatment Market Size by Type (2015-2020)
8.4 China Obesity Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Obesity Treatment Market Size (2015-2020)
9.2 Obesity Treatment Key Players in Japan (2019-2020)
9.3 Japan Obesity Treatment Market Size by Type (2015-2020)
9.4 Japan Obesity Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Obesity Treatment Market Size (2015-2020)
10.2 Obesity Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Obesity Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Obesity Treatment Market Size by Application (2015-2020)
11 India
11.1 India Obesity Treatment Market Size (2015-2020)
11.2 Obesity Treatment Key Players in India (2019-2020)
11.3 India Obesity Treatment Market Size by Type (2015-2020)
11.4 India Obesity Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Obesity Treatment Market Size (2015-2020)
12.2 Obesity Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Obesity Treatment Market Size by Type (2015-2020)
12.4 Central & South America Obesity Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 NutriSystem, Inc. (U.S.)
13.1.1 NutriSystem, Inc. (U.S.) Company Details
13.1.2 NutriSystem, Inc. (U.S.) Business Overview
13.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Introduction
13.1.4 NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2015-2020))
13.1.5 NutriSystem, Inc. (U.S.) Recent Development
13.2 Kellogg Company (U.S.)
13.2.1 Kellogg Company (U.S.) Company Details
13.2.2 Kellogg Company (U.S.) Business Overview
13.2.3 Kellogg Company (U.S.) Obesity Treatment Introduction
13.2.4 Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2015-2020)
13.2.5 Kellogg Company (U.S.) Recent Development
13.3 Ethicon, Inc. (U.S.)
13.3.1 Ethicon, Inc. (U.S.) Company Details
13.3.2 Ethicon, Inc. (U.S.) Business Overview
13.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Introduction
13.3.4 Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2015-2020)
13.3.5 Ethicon, Inc. (U.S.) Recent Development
13.4 Medtronic (U.S.)
13.4.1 Medtronic (U.S.) Company Details
13.4.2 Medtronic (U.S.) Business Overview
13.4.3 Medtronic (U.S.) Obesity Treatment Introduction
13.4.4 Medtronic (U.S.) Revenue in Obesity Treatment Business (2015-2020)
13.4.5 Medtronic (U.S.) Recent Development
13.5 F. Hoffmann-La Roche (Switzerland)
13.5.1 F. Hoffmann-La Roche (Switzerland) Company Details
13.5.2 F. Hoffmann-La Roche (Switzerland) Business Overview
13.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Introduction
13.5.4 F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2015-2020)
13.5.5 F. Hoffmann-La Roche (Switzerland) Recent Development
13.6 Atkins Nutritionals, Inc. (U.S.)
13.6.1 Atkins Nutritionals, Inc. (U.S.) Company Details
13.6.2 Atkins Nutritionals, Inc. (U.S.) Business Overview
13.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Introduction
13.6.4 Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2015-2020)
13.6.5 Atkins Nutritionals, Inc. (U.S.) Recent Development
13.7 Herbalife Ltd. (U.S.)
13.7.1 Herbalife Ltd. (U.S.) Company Details
13.7.2 Herbalife Ltd. (U.S.) Business Overview
13.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Introduction
13.7.4 Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2015-2020)
13.7.5 Herbalife Ltd. (U.S.) Recent Development
13.8 Covidien plc (U.S.)
13.8.1 Covidien plc (U.S.) Company Details
13.8.2 Covidien plc (U.S.) Business Overview
13.8.3 Covidien plc (U.S.) Obesity Treatment Introduction
13.8.4 Covidien plc (U.S.) Revenue in Obesity Treatment Business (2015-2020)
13.8.5 Covidien plc (U.S.) Recent Development
13.9 Apollo Endosurgery (U.S.)
13.9.1 Apollo Endosurgery (U.S.) Company Details
13.9.2 Apollo Endosurgery (U.S.) Business Overview
13.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Introduction
13.9.4 Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2015-2020)
13.9.5 Apollo Endosurgery (U.S.) Recent Development
13.10 Amer Sports (Finland)
13.10.1 Amer Sports (Finland) Company Details
13.10.2 Amer Sports (Finland) Business Overview
13.10.3 Amer Sports (Finland) Obesity Treatment Introduction
13.10.4 Amer Sports (Finland) Revenue in Obesity Treatment Business (2015-2020)
13.10.5 Amer Sports (Finland) Recent Development
13.11 Johnson Health Technology, Ltd. (Taiwan)
10.11.1 Johnson Health Technology, Ltd. (Taiwan) Company Details
10.11.2 Johnson Health Technology, Ltd. (Taiwan) Business Overview
10.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Introduction
10.11.4 Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2015-2020)
10.11.5 Johnson Health Technology, Ltd. (Taiwan) Recent Development
13.12 Cybex International (U.S.)
10.12.1 Cybex International (U.S.) Company Details
10.12.2 Cybex International (U.S.) Business Overview
10.12.3 Cybex International (U.S.) Obesity Treatment Introduction
10.12.4 Cybex International (U.S.) Revenue in Obesity Treatment Business (2015-2020)
10.12.5 Cybex International (U.S.) Recent Development
13.13 USGI Medical (U.S.)
10.13.1 USGI Medical (U.S.) Company Details
10.13.2 USGI Medical (U.S.) Business Overview
10.13.3 USGI Medical (U.S.) Obesity Treatment Introduction
10.13.4 USGI Medical (U.S.) Revenue in Obesity Treatment Business (2015-2020)
10.13.5 USGI Medical (U.S.) Recent Development
13.14 Olympus Corporation (Japan)
10.14.1 Olympus Corporation (Japan) Company Details
10.14.2 Olympus Corporation (Japan) Business Overview
10.14.3 Olympus Corporation (Japan) Obesity Treatment Introduction
10.14.4 Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2015-2020)
10.14.5 Olympus Corporation (Japan) Recent Development
13.15 Brunswick Corporation (U.S.)
10.15.1 Brunswick Corporation (U.S.) Company Details
10.15.2 Brunswick Corporation (U.S.) Business Overview
10.15.3 Brunswick Corporation (U.S.) Obesity Treatment Introduction
10.15.4 Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2015-2020)
10.15.5 Brunswick Corporation (U.S.) Recent Development
13.16 Technogym SpA (Italy)
10.16.1 Technogym SpA (Italy) Company Details
10.16.2 Technogym SpA (Italy) Business Overview
10.16.3 Technogym SpA (Italy) Obesity Treatment Introduction
10.16.4 Technogym SpA (Italy) Revenue in Obesity Treatment Business (2015-2020)
10.16.5 Technogym SpA (Italy) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Obesity Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Obesity Treatment Revenue
Table 3. Ranking of Global Top Obesity Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Obesity Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgical & Implant Devices
Table 6. Key Players of Medication Therapy
Table 7. Key Players of Dietary
Table 8. Key Players of Other
Table 9. Global Obesity Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Obesity Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Obesity Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Obesity Treatment Market Share by Regions (2015-2020)
Table 13. Global Obesity Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Obesity Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Obesity Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Obesity Treatment Players
Table 20. Global Obesity Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Obesity Treatment Market Share by Players (2015-2020)
Table 22. Global Top Obesity Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obesity Treatment as of 2019)
Table 23. Global Obesity Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Obesity Treatment Product Solution and Service
Table 26. Date of Enter into Obesity Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Obesity Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Obesity Treatment Market Size Share by Type (2015-2020)
Table 30. Global Obesity Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Obesity Treatment Market Size Share by Application (2015-2020)
Table 32. Global Obesity Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Obesity Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Obesity Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Obesity Treatment Market Share (2019-2020)
Table 36. North America Obesity Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Obesity Treatment Market Share by Type (2015-2020)
Table 38. North America Obesity Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Obesity Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Obesity Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Obesity Treatment Market Share (2019-2020)
Table 42. Europe Obesity Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Obesity Treatment Market Share by Type (2015-2020)
Table 44. Europe Obesity Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Obesity Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Obesity Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Obesity Treatment Market Share (2019-2020)
Table 48. China Obesity Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Obesity Treatment Market Share by Type (2015-2020)
Table 50. China Obesity Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Obesity Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Obesity Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Obesity Treatment Market Share (2019-2020)
Table 54. Japan Obesity Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Obesity Treatment Market Share by Type (2015-2020)
Table 56. Japan Obesity Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Obesity Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Obesity Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Obesity Treatment Market Share (2019-2020)
Table 60. Southeast Asia Obesity Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Obesity Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Obesity Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Obesity Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Obesity Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Obesity Treatment Market Share (2019-2020)
Table 66. India Obesity Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Obesity Treatment Market Share by Type (2015-2020)
Table 68. India Obesity Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Obesity Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Obesity Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Obesity Treatment Market Share (2019-2020)
Table 72. Central & South America Obesity Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Obesity Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Obesity Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Obesity Treatment Market Share by Application (2015-2020)
Table 76. NutriSystem, Inc. (U.S.) Company Details
Table 77. NutriSystem, Inc. (U.S.) Business Overview
Table 78. NutriSystem, Inc. (U.S.) Product
Table 79. NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 80. NutriSystem, Inc. (U.S.) Recent Development
Table 81. Kellogg Company (U.S.) Company Details
Table 82. Kellogg Company (U.S.) Business Overview
Table 83. Kellogg Company (U.S.) Product
Table 84. Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 85. Kellogg Company (U.S.) Recent Development
Table 86. Ethicon, Inc. (U.S.) Company Details
Table 87. Ethicon, Inc. (U.S.) Business Overview
Table 88. Ethicon, Inc. (U.S.) Product
Table 89. Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 90. Ethicon, Inc. (U.S.) Recent Development
Table 91. Medtronic (U.S.) Company Details
Table 92. Medtronic (U.S.) Business Overview
Table 93. Medtronic (U.S.) Product
Table 94. Medtronic (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 95. Medtronic (U.S.) Recent Development
Table 96. F. Hoffmann-La Roche (Switzerland) Company Details
Table 97. F. Hoffmann-La Roche (Switzerland) Business Overview
Table 98. F. Hoffmann-La Roche (Switzerland) Product
Table 99. F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 100. F. Hoffmann-La Roche (Switzerland) Recent Development
Table 101. Atkins Nutritionals, Inc. (U.S.) Company Details
Table 102. Atkins Nutritionals, Inc. (U.S.) Business Overview
Table 103. Atkins Nutritionals, Inc. (U.S.) Product
Table 104. Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 105. Atkins Nutritionals, Inc. (U.S.) Recent Development
Table 106. Herbalife Ltd. (U.S.) Company Details
Table 107. Herbalife Ltd. (U.S.) Business Overview
Table 108. Herbalife Ltd. (U.S.) Product
Table 109. Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 110. Herbalife Ltd. (U.S.) Recent Development
Table 111. Covidien plc (U.S.) Business Overview
Table 112. Covidien plc (U.S.) Product
Table 113. Covidien plc (U.S.) Company Details
Table 114. Covidien plc (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 115. Covidien plc (U.S.) Recent Development
Table 116. Apollo Endosurgery (U.S.) Company Details
Table 117. Apollo Endosurgery (U.S.) Business Overview
Table 118. Apollo Endosurgery (U.S.) Product
Table 119. Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 120. Apollo Endosurgery (U.S.) Recent Development
Table 121. Amer Sports (Finland) Company Details
Table 122. Amer Sports (Finland) Business Overview
Table 123. Amer Sports (Finland) Product
Table 124. Amer Sports (Finland) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 125. Amer Sports (Finland) Recent Development
Table 126. Johnson Health Technology, Ltd. (Taiwan) Company Details
Table 127. Johnson Health Technology, Ltd. (Taiwan) Business Overview
Table 128. Johnson Health Technology, Ltd. (Taiwan) Product
Table 129. Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 130. Johnson Health Technology, Ltd. (Taiwan) Recent Development
Table 131. Cybex International (U.S.) Company Details
Table 132. Cybex International (U.S.) Business Overview
Table 133. Cybex International (U.S.) Product
Table 134. Cybex International (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 135. Cybex International (U.S.) Recent Development
Table 136. USGI Medical (U.S.) Company Details
Table 137. USGI Medical (U.S.) Business Overview
Table 138. USGI Medical (U.S.) Product
Table 139. USGI Medical (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 140. USGI Medical (U.S.) Recent Development
Table 141. Olympus Corporation (Japan) Company Details
Table 142. Olympus Corporation (Japan) Business Overview
Table 143. Olympus Corporation (Japan) Product
Table 144. Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 145. Olympus Corporation (Japan) Recent Development
Table 146. Brunswick Corporation (U.S.) Company Details
Table 147. Brunswick Corporation (U.S.) Business Overview
Table 148. Brunswick Corporation (U.S.) Product
Table 149. Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 150. Brunswick Corporation (U.S.) Recent Development
Table 151. Technogym SpA (Italy) Company Details
Table 152. Technogym SpA (Italy) Business Overview
Table 153. Technogym SpA (Italy) Product
Table 154. Technogym SpA (Italy) Revenue in Obesity Treatment Business (2015-2020) (Million US$)
Table 155. Technogym SpA (Italy) Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Obesity Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgical & Implant Devices Features
Figure 3. Medication Therapy Features
Figure 4. Dietary Features
Figure 5. Other Features
Figure 6. Global Obesity Treatment Market Share by Application: 2020 VS 2026
Figure 7. Children Case Studies
Figure 8. Adults Case Studies
Figure 9. Obesity Treatment Report Years Considered
Figure 10. Global Obesity Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Obesity Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Obesity Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Obesity Treatment Market Share by Players in 2019
Figure 15. Global Top Obesity Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obesity Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Obesity Treatment Revenue in 2019
Figure 17. North America Obesity Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Obesity Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Obesity Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Obesity Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Obesity Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Obesity Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Obesity Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
肥満管理の世界市場（～2026年） Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed wor…- 抗肥満薬（抗肥満薬）の世界市場（～2026年） Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. Market Analysis and Insights: Global Ant…
- 抗肥満薬の世界市場（～2026年） Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain diet…
- 抗肥満処方の世界市場（～2026年） Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory …
- 抗肥満療法の世界市場（～2026年） Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways. Geographically, North America captures the largest …